Skip to main content
Equibles

ABVX · Abivax S.A. · Investor Relations

Track ABVX — free

Use ABVX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABVX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$88.15 -0.90 (-1.01%) At close · Oct 9
Rebalance outlook locked
Market Cap
$7.69B
Shares
87.27M
Volume · Oct 9 885.32K Avg daily vol (3M) 1.11M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-12-14 00:00 UTC Q3 2026 Financial Results Results publication

Past events

Date Event Type
2026-09-21 H1 2026 Financial Results Results publication
2026-06-29 ABTECT Maintenance Part 2 Results Webcast Earnings call
2026-06-01 ABTECT Maintenance Results Investor Webcast Earnings call
2026-05-22 Q1 2026 Financial Results Results publication
2026-05-11 2026 Annual General Meeting (AGM) Shareholder meeting
2026-03-23 FY 2025 Financial Results Results publication
2026-03-23 Full Year 2025 Financial Results Results publication
2025-10-06 Abivax Management Call to Discuss Late-Breaking Abstract at UEG Conference Conference
2025-10-06 Abivax Industry Symposium at UEG Week 2025 Webcast
2025-09-08 2025 Half-Year Business and Financial Report (as of June 30, 2025) Event
2025-07-22 Abivax Investor Call Webcast
2025-06-06 2025 Annual General Meeting (AGM) Shareholder meeting
2025-06-02 2025 Q1 Financial Results (as of March 31, 2025) Results publication
2025-03-24 2024 Annual Business and Financial Report (as of December 31, 2024) Event
2025-03-17 Virtual KOL Investor Event Event
2024-11-07 Third Quarter 2024 Financial Information (as of September 30, 2024) Event
2024-09-09 2024 Half-Year Business and Financial Report (as of June 30, 2024) Event
2024-05-30 Shareholders’ Meeting Shareholder meeting
2024-04-08 Abivax webcast on 2023 financial results Earnings call
2024-04-02 2023 Annual Business and Financial Report (as of December 31, 2023) Event
2024-03-12 Replay: Abivax Presentation at Leerink Partners Global Biopharma Conference 2024 Conference
2024-02-23 Replay: Abivax scientific symposium at ECCO Event
2024-02-06 Virtual KOL Investor Event Event
2024-01-25 Crohn’s & Colitis Congress Event
2023-11-28 Piper Sandler 35th Annual Healthcare Conference Conference

Source: https://ir.abivax.com/

Key facts CIK 1956827 CUSIP 00370M103 13F (30d) 14 filings 14 filers Visit website Investor relations